NPT200-11
NPT200-11 is an orally administered, brain-penetrant small molecule that inhibits the misfolding and aggregation of alpha-synuclein. It serves as a research tool for investigating synucleinopathies such as Parkinson's disease, dementia with Lewy bodies, and Multiple System Atrophy in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
2227057-23-8
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-284782 100 mg
6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid
Sign In for Pricing
View Details 